PROCEPT BioRobotics Corporation Common Stock (PRCT)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of PROCEPT BioRobotics Corporation Common Stock (PRCT)
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Key Insights
Critical company metrics and information
Share Price
$92.78Market Cap
$5.02 BillionTotal Outstanding Shares
54.11 Million SharesTotal Employees
626Dividend
No dividendIPO Date
September 15, 2021SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.procept-biorobotics.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities | $172.87 Million |
Net Cash Flow From Financing Activities, Continuing | $172.87 Million |
Net Cash Flow From Investing Activities | $-17.48 Million |
Net Cash Flow From Operating Activities, Continuing | $-91.76 Million |
Net Cash Flow, Continuing | $63.63 Million |
Net Cash Flow From Operating Activities | $-91.76 Million |
Net Cash Flow From Investing Activities, Continuing | $-17.48 Million |
Net Cash Flow | $63.63 Million |
Income Statement
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Income/Loss From Continuing Operations After Tax | $-103.71 Million |
Selling, General, and Administrative Expenses | $149.61 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Income/Loss From Continuing Operations Before Tax | $176.57 Million |
Operating Expenses | $206.29 Million |
Operating Income/Loss | $-109.64 Million |
Net Income/Loss | $-103.71 Million |
Basic Average Shares | $100.75 Million |
Cost Of Revenue | $79.93 Million |
Net Income/Loss Available To Common Stockholders, Basic | $-103.71 Million |
Basic Earnings Per Share | $-2.06 |
Costs And Expenses | $286.22 Million |
Diluted Earnings Per Share | $-2.06 |
Research and Development | $56.68 Million |
Net Income/Loss Attributable To Parent | $-103.71 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Diluted Average Shares | $100.75 Million |
Gross Profit | $96.64 Million |
Revenues | $176.57 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Benefits Costs and Expenses | $0.00 |
Balance Sheet
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Other Non-current Liabilities | $28.32 Million |
Other Non-current Assets | $24.78 Million |
Noncurrent Assets | $52.46 Million |
Accounts Payable | $9.95 Million |
Long-term Debt | $51.40 Million |
Liabilities | $122.57 Million |
Liabilities And Equity | $374.35 Million |
Assets | $374.35 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Assets | $278.03 Million |
Other Current Liabilities | $32.90 Million |
Equity Attributable To Parent | $251.78 Million |
Current Assets | $321.89 Million |
Noncurrent Liabilities | $79.73 Million |
Inventory | $43.87 Million |
Fixed Assets | $27.68 Million |
Equity | $251.78 Million |
Current Liabilities | $42.84 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.